MMED logo

MMED
MiniMed Group Inc

3,463
Mkt Cap
$3.38B
Volume
574,190.00
52W High
$20.48
52W Low
$10.65
Price
$12.04
MMED Fundamentals
Prev Close
$11.51
Open
$11.85
50D MA
$13.16
Beta
0.00
Avg. Volume
878,880.84
P/B
0.98
Loading...
Loading...
News
all
press releases
MiniMed to Showcase MiniMed Flex and MiniMed Go at the American Diabetes Association Scientific Sessions
MiniMed to Showcase MiniMed Flex and MiniMed Go at the American Diabetes Association Scientific Sessions MiniMed to Showcase MiniMed Flex and MiniMed Go at the American Diabetes Association Scientific Sessions PR Newswire NORTHRIDGE, Calif., May 27, 2026 Following this week's launch of MiniMed Go...
PR Newswire
News Placeholder
More News
News Placeholder
MiniMed to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
MiniMed to Participate in Goldman Sachs 47th Annual Global Healthcare Conference MiniMed to Participate in Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire NORTHRIDGE, Calif., May 26, 2026 NORTHRIDGE, Calif., May 26, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in...
PR Newswire
News Placeholder
MMED's Latest Study Supports the Strength of 780G SmartGuard Algorithm
MiniMed study results show MiniMed 780G delivering consistent glycemic outcomes across sensors, reinforcing SmartGuard's strength.
Zacks
News Placeholder
New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System
New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System PR Newswire NORTHRIDGE, Calif., May 21, 2026 Randomized crossover trial reinforces SmartGuard algorithm...
PR Newswire
News Placeholder
MiniMed Group (NASDAQ:MMED) Hits New 52-Week Low - Here's What Happened
MiniMed Group (NASDAQ:MMED) Sets New 1-Year Low - Should You Sell...
MarketBeat
News Placeholder
MiniMed Group (NASDAQ:MMED) Hits New 1-Year Low - Should You Sell?
MiniMed Group (NASDAQ:MMED) Sets New 52-Week Low - Here's Why...
MarketBeat
News Placeholder
MiniMed Group Inc (NASDAQ:MMED) Receives Consensus Recommendation of "Moderate Buy" from Analysts
MiniMed Group Inc (NASDAQ:MMED - Get Free Report) has received a consensus rating of "Moderate Buy" from the thirteen brokerages that are covering the company, Marketbeat Ratings reports. Two...
MarketBeat
News Placeholder
MiniMed Group (NASDAQ:MMED) Reaches New 1-Year Low - Time to Sell?
MiniMed Group (NASDAQ:MMED) Reaches New 1-Year Low - Here's Why...
MarketBeat
News Placeholder
MiniMed Group (NASDAQ:MMED) Releases Quarterly Earnings Results
MiniMed Group (NASDAQ:MMED - Get Free Report) announced its quarterly earnings results on Friday. The company reported $999.00 EPS for the quarter...
MarketBeat
News Placeholder
Goldman Sachs' 2 Favorite Under-the-Radar Stocks
Goldman Sachs calls Minimed Group a compelling play on the diabetes market and a potentially profitable stock, with a target price of $24. MiniMed produces insulin pump platforms and continuous...
Benzinga
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available